CUFinder

Anders Själander

About Anders Själander

Anders Själander, With an exceptional h-index of 34 and a recent h-index of 21 (since 2020), a distinguished researcher at Umeå universitet, specializes in the field of Koagulation. Hematologi. Medicin.

His recent articles reflect a diverse array of research interests and contributions to the field:

Improved adherence to statin treatment and differences in results between men and women after pictorial risk communication—a sub-study of the VIPVIZA RCT

ABO Blood Groups, RhD Factor and Their Association with Subclinical Atherosclerosis Assessed by Carotid Ultrasonography

Thromboembolic events, major bleeding and mortality in essential thrombocythaemia and polycythaemia vera—A matched nationwide population‐based study

Prevalence of atrial fibrillation and reasons for undertreatment with oral anticoagulants

Entrustable professional activities (EPAs) for undergraduate medical education–development and exploration of social validity

Warfarin treatment quality and outcomes in patients with non-valvular atrial fibrillation and CKD G3-G5D

Direct oral anticoagulants: patient reported adherence and minor bleedings

Erythrocytosis, thrombocytosis, and rate of recurrent thromboembolic event—A population based cohort study

Anders Själander Information

University

Position

___

Citations(all)

4829

Citations(since 2020)

1705

Cited By

3754

hIndex(all)

34

hIndex(since 2020)

21

i10Index(all)

57

i10Index(since 2020)

37

Email

University Profile Page

Google Scholar

Anders Själander Skills & Research Interests

Koagulation. Hematologi. Medicin

Top articles of Anders Själander

Improved adherence to statin treatment and differences in results between men and women after pictorial risk communication—a sub-study of the VIPVIZA RCT

European Journal of Clinical Pharmacology

2024/4/29

Anders Själander
Anders Själander

H-Index: 22

ABO Blood Groups, RhD Factor and Their Association with Subclinical Atherosclerosis Assessed by Carotid Ultrasonography

Journal of Clinical Medicine

2024/2/27

Anders Själander
Anders Själander

H-Index: 22

Thromboembolic events, major bleeding and mortality in essential thrombocythaemia and polycythaemia vera—A matched nationwide population‐based study

British Journal of Haematology

2024/2/13

Henrik Renlund
Henrik Renlund

H-Index: 16

Anders Själander
Anders Själander

H-Index: 22

Prevalence of atrial fibrillation and reasons for undertreatment with oral anticoagulants

Journal of Thrombosis and Thrombolysis

2024/1

Johan Lilja
Johan Lilja

H-Index: 10

Anders Själander
Anders Själander

H-Index: 22

Entrustable professional activities (EPAs) for undergraduate medical education–development and exploration of social validity

BMC Medical Education

2023/9/4

Mattias Ekstedt
Mattias Ekstedt

H-Index: 23

Magnus Hultin
Magnus Hultin

H-Index: 13

Katarina Jood
Katarina Jood

H-Index: 26

Anders Själander
Anders Själander

H-Index: 22

Warfarin treatment quality and outcomes in patients with non-valvular atrial fibrillation and CKD G3-G5D

Thrombosis Research

2023/9/1

Henrik Renlund
Henrik Renlund

H-Index: 16

Anders Själander
Anders Själander

H-Index: 22

Direct oral anticoagulants: patient reported adherence and minor bleedings

Journal of Thrombosis and Thrombolysis

2023/7

Anders Själander
Anders Själander

H-Index: 22

Erythrocytosis, thrombocytosis, and rate of recurrent thromboembolic event—A population based cohort study

European Journal of Haematology

2023/6

Anders Själander
Anders Själander

H-Index: 22

The impact of Covid-19 in patients with chronic myeloid leukemia—a nationwide population-based study

Leukemia

2023/5

Torsten Dahlén
Torsten Dahlén

H-Index: 5

Anders Själander
Anders Själander

H-Index: 22

Susannah Leach
Susannah Leach

H-Index: 5

Huiqi Li
Huiqi Li

H-Index: 12

Fredrik Nyberg
Fredrik Nyberg

H-Index: 35

Direct oral anticoagulants versus warfarin in patients with non-valvular atrial fibrillation and CKD G3–G5D

Clinical Kidney Journal

2023/5

Henrik Renlund
Henrik Renlund

H-Index: 16

Anders Själander
Anders Själander

H-Index: 22

Reduced dose direct oral anticoagulants compared with warfarin with high time in therapeutic range in nonvalvular atrial fibrillation

Journal of Thrombosis and Thrombolysis

2023/4

Henrik Renlund
Henrik Renlund

H-Index: 16

Anders Själander
Anders Själander

H-Index: 22

Celiac disease and upper secondary school achievement in Sweden A retrospective cohort study

BMC pediatrics

2022/12/12

Katarina Johansson
Katarina Johansson

H-Index: 16

Anneli Ivarsson
Anneli Ivarsson

H-Index: 29

Linda Richter Sundberg
Linda Richter Sundberg

H-Index: 7

Anders Själander
Anders Själander

H-Index: 22

Improved adherence to statins following pictorial intervention. Sub study of visualization of subclinical atherosclerotic disease for optimum cardiovascular prevention (VIPVIZA)

European Heart Journal

2022/10/1

P1021: ERYTHROCYTOSIS, THROMBOCYTOSIS AND RATE OF RECURRENT THROMBOEMBOLIC EVENT-A POPULATION BASED COHORT STUDY

HemaSphere

2022/6/1

Anders Själander
Anders Själander

H-Index: 22

Incidence and risk factors of venous thromboembolism in men and women

Archives of surgery

2011/6/1

John Choi
John Choi

H-Index: 7

Andrew Barleben
Andrew Barleben

H-Index: 12

John Lane
John Lane

H-Index: 5

Ninh Nguyen
Ninh Nguyen

H-Index: 18

Steven Mills
Steven Mills

H-Index: 16

MO758: Warfarin Treatment Quality and Outcomes in Patients with Non-Valvular Atrial Fibrillation and Chronic Kidney Disease Including Patients on Dialysis

Nephrology Dialysis Transplantation

2022/5

Henrik Renlund
Henrik Renlund

H-Index: 16

Anders Själander
Anders Själander

H-Index: 22

Adverse outcomes in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: follow‐up of patients diagnosed 2002–2017 in a complete coverage and nationwide …

American Journal of Hematology

2022/4

Torsten Dahlén
Torsten Dahlén

H-Index: 5

Gustaf Edgren
Gustaf Edgren

H-Index: 30

Johan Richter
Johan Richter

H-Index: 29

Anders Själander
Anders Själander

H-Index: 22

Time to initiation of lipid-lowering drugs for subclinical atherosclerosis: sub-study of VIPVIZA randomized controlled trial, with single-arm cross-over

European Heart Journal Open

2022/1/1

Anders Själander
Anders Själander

H-Index: 22

Prevalence of subclinical coronary artery atherosclerosis in the general population

Circulation

2021/9/21

Elias Björnson
Elias Björnson

H-Index: 13

Carl Bonander
Carl Bonander

H-Index: 7

Anders Blomberg
Anders Blomberg

H-Index: 25

Mats Eriksson
Mats Eriksson

H-Index: 16

Isabel Gonçalves
Isabel Gonçalves

H-Index: 22

Lars Lind
Lars Lind

H-Index: 4

Eva Lindberg
Eva Lindberg

H-Index: 40

Martin Magnusson
Martin Magnusson

H-Index: 17

Ellen Ostenfeld
Ellen Ostenfeld

H-Index: 11

Anders Persson
Anders Persson

H-Index: 24

Anders Själander
Anders Själander

H-Index: 22

Johan Sundström
Johan Sundström

H-Index: 64

Molecular status 36 months after TKI discontinuation in CML is highly predictive for subsequent loss of MMR—final report from AFTER-SKI

Leukemia

2021/8

Johan Richter
Johan Richter

H-Index: 29

Kourosh Lotfi
Kourosh Lotfi

H-Index: 14

Anders Själander
Anders Själander

H-Index: 22

Stefan Deneberg
Stefan Deneberg

H-Index: 12

See List of Professors in Anders Själander University(Umeå universitet)